Moderna (MRNA) remains comfortable with its guided range for FY23 Covid vaccine sales
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- S&P Downgrades Oracle To 'bbb-/A-3'; Outlook Stable
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Citi names top picks in software ahead of Q2 earnings
Moderna (MRNA) 'remains comfortable' with Covid vaccine guidance range after Pfizer slashes forecast
October 16, 2023 2:29 PM EDTPharmaceutical company Moderna (NASDAQ: MRNA) released a short statement Monday, aiming to ease worries regarding sales of its Coivd vaccine.
The company's share price dropped Monday after larger rival Pfizer (NYSE: PFE) slashed its 2023 revenue projection by $9 billion late Friday.... More
Apple, Nvidia and Pfizer fall premarket; Lululemon rises
October 16, 2023 8:20 AM EDTInvesting.com -- U.S. futures edged higher Monday, at the start of a week that sees the quarterly earnings season ramp up.
Here are some of the biggest premarket U.S. stock movers today:
Rite Aid (NYSE: RAD) stock rose 4.5%, rebounding after Fridays 17% drop, after the... More
